The French National Institute of Cancer has Selected the CyberKnife System as an Innovative Treatment Option in Radiation Oncology
Paris, France, March 1, 2006 - Accuray Incorporated, the global leader in the field of robotic radiosurgery, announced today that three CyberKnife® Systems will be installed in France. The French National Institute of Cancer (INCa) has selected the CyberKnife Robotic Radiosurgery System in its programme to promote innovative treatments in the field of radiation oncology.
Three prestigious academic cancer centres have been selected by an international committee of radiation oncologists, physicists and surgeons. The sites are the Centres de Lutte contre le Cancer Oscar Lambret in Lille (in cooperation with the University Hospital of Lille), Alexis Vautrin in Nancy, and Antoine Lacassagne in Nice. The committee evaluated the clinical and scientific expertise of each team and their experience in high precision radiation oncology before making their selection.
Accuray is very excited by the prospect of working with such a prestigious group of French Hospitals and is pleased with INCas recognition of the unique contribution the CyberKnife provides to cancer care, said Karl Blohm, general manager, Europe of Accuray, Europe S.A.R.L. The CyberKnife is the worlds first and only robotic radiosurgery system designed to treat solid tumors anywhere in the body. With proven total clinical accuracy of less than one millimeter, the CyberKnife is the next generation in Radiosurgery.
About the CyberKnife Robotic Radiosurgery System
The CyberKnife System is the world’s first and only radiosurgery system that utilizes intelligent robotics to treat tumors anywhere in the body. The CyberKnife System treats patients in single or staged (typically 2-5) sessions by delivering multiple beams of precisely directed radiation that converge upon the tumor while minimizing injury to surrounding healthy tissue. Image guidance and computer controlled robotics combine to continuously track, detect and correct for tumor and patient movements throughout the treatment with sub-millimeter accuracy. Because of this extreme precision and accuracy, no head or body frame is required. The CyberKnife has proven to attract a new patient population to a physician’s practice and complements existing radiation therapy, IMRT or IGRT programs.
About Accuray Inc.
Accuray Incorporated, a privately held company based in Sunnyvale, California, is the global leader in the field of robotic radiosurgery. Its CyberKnife System is the world ’s first and only intelligent robotic radiosurgery system designed to treat tumors anywhere in the body with sub-millimeter accuracy. More than 100 CyberKnife Systems have been purchased by leading medical centers throughout the world and a large body of peer-reviewed papers supports its clinical practice. To date, the CyberKnife has treated more than 18,000 patients worldwide. For more information, please visit http://www.accuray.com.
2006 All rights reserved. Accuray, the Accuray logo, and CyberKnife are among trademarks or registered trademarks of Accuray Inc.